Mike Banville is CEO of ALZpath; a company on a mission to change how we detect Alzheimer’s, earlier and more accessibly. With a career spent leading & growing companies across healthcare and technology, Mike now brings his leadership to a cause that affects millions of families around the world.
In this episode we learn how Mike and his team at ALZpath are making diagnostics more accessible and affordable, potentially transforming the way we approach this dementia. Mike shares insights on the current diagnostics landscape, future prospects, and the importance of democratizing healthcare.
In this episode, I explore explore the origin story of Alois Alzheimer. Stay tuned for more dementia related explorations, breakdowns and interviews- please follow...
Professor Chris Fox, a psychiatrist and internationally recognised expert in ageing, dementia care, and health services research. He is Professor of Clinical Psychiatry at...
Linda Sommerlade serves as the Head of Operations at GT Diagnostics, a collaboration between Genting Berhad, a Malaysian company, and TauRx Pharmaceuticals Ltd Group, ...
